PubMed

Treatment of lipodystrophy with troglitazone.

Cheng JS.

Ann Intern Med. 2001 Jun 19;134(12):1153-4. No abstract available. PMID: 11412067 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of troglitazone for lipodystrophy syndromes.

Caldwell SH.

Ann Intern Med. 2001 May 15;134(10):1008. No abstract available. PMID: 11352703 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipoatrophy, lipodystrophy, and insulin resistance.

Ganda OP.

Ann Intern Med. 2000 Aug 15;133(4):304-6. No abstract available. PMID: 10929174 [PubMed - indexed for MEDLINE]Related articlesFree article

Troglitazone: a possible modulator of ovarian steroidogenesis.

Mitwally MF, Witchel SF, Casper RF.

J Soc Gynecol Investig. 2002 May-Jun;9(3):163-7.PMID: 12009391 [PubMed - indexed for MEDLINE]Related articles

From fat-free mice, the skinny on diabetes.

Gura T.

Science. 1998 Oct 23;282(5389):604. No abstract available. PMID: 9841407 [PubMed - indexed for MEDLINE]Related articles

Troglitazone-induced pulmonary edema.

Inoue K, Sano H.

Arch Intern Med. 2000 Mar 27;160(6):871-2. No abstract available. PMID: 10737290 [PubMed - indexed for MEDLINE]Related articles

Troglitazone as an anti-inflammatory agent.

Inoue K, Kawahito Y, Sano H.

Arch Intern Med. 2000 Oct 23;160(19):3004. No abstract available. PMID: 11041910 [PubMed - indexed for MEDLINE]Related articles

Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.

Parker JC.

Adv Drug Deliv Rev. 2002 Nov 5;54(9):1173-97. Review.PMID: 12393300 [PubMed - indexed for MEDLINE]Related articles

Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo.

Kalderon B, Mayorek N, Ben-Yaacov L, Bar-Tana J.

Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E795-803. Epub 2002 Dec 17.PMID: 12488241 [PubMed - indexed for MEDLINE]Related articlesFree article

Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects.

Ciaraldi TP, Kong AP, Chu NV, Kim DD, Baxi S, Loviscach M, Plodkowski R, Reitz R, Caulfield M, Mudaliar S, Henry RR.

Diabetes. 2002 Jan;51(1):30-6.PMID: 11756319 [PubMed - indexed for MEDLINE]Related articlesFree article

Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice.

Tornvig L, Mosekilde LI, Justesen J, Falk E, Kassem M.

Calcif Tissue Int. 2001 Jul;69(1):46-50. Epub 2001 Jun 13.PMID: 11685433 [PubMed - indexed for MEDLINE]Related articles

Troglitazone use in polycystic ovary syndrome.

Landman RE, Jacobs TP.

J Clin Endocrinol Metab. 2001 Oct;86(10):5090-1. No abstract available. PMID: 11600596 [PubMed - indexed for MEDLINE]Related articles

Troglitazone protects human erythrocytes from oxidant damage.

May JM, Qu ZC.

Antioxid Redox Signal. 2000 Summer;2(2):243-50.PMID: 11229529 [PubMed - indexed for MEDLINE]Related articles

Troglitazone ameliorates abnormal activity of protein tyrosine phosphatase in adipose tissues of Otsuka Long-Evans Tokushima Fatty rats.

Tagami S, Honda T, Yoshimura H, Homma H, Ohno K, Ide H, Sakaue S, Kawakami Y.

Tohoku J Exp Med. 2002 Jul;197(3):169-81.PMID: 12365558 [PubMed - indexed for MEDLINE]Related articlesFree article

Antineoplastic and anti-inflammatory effects of PPAR ligands in colitis.

Su CG, Lewis JD.

Gastroenterology. 2001 Oct;121(4):1019-21. No abstract available. PMID: 11606520 [PubMed - indexed for MEDLINE]Related articles

Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.

Furuta M, Yano Y, Gabazza EC, Araki-Sasaki R, Tanaka T, Katsuki A, Hori Y, Nakatani K, Sumida Y, Adachi Y.

Diabetes Res Clin Pract. 2002 Jun;56(3):159-71.PMID: 11947963 [PubMed - indexed for MEDLINE]Related articles

Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.

Fukuda N, Hu WY, Teng J, Chikara S, Nakayama M, Kishioka H, Kanmatsuse K.

Atherosclerosis. 2002 Aug;163(2):229-39.PMID: 12052469 [PubMed - indexed for MEDLINE]Related articles

Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action?

Aljada A, Garg R, Ghanim H, Mohanty P, Hamouda W, Assian E, Dandona P.

J Clin Endocrinol Metab. 2001 Jul;86(7):3250-6.PMID: 11443197 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial.

Nakamura T, Funahashi T, Yamashita S, Nishida M, Nishida Y, Takahashi M, Hotta K, Kuriyama H, Kihara S, Ohuchi N, Nishimura T, Kishino BI, Ishikawa K, Kawamoto T, Tokunaga K, Nakagawa C, Mineo I, Watanabe F, Tarui S, Matsuzawa Y.

Diabetes Res Clin Pract. 2001 Dec;54(3):181-90.PMID: 11689273 [PubMed - indexed for MEDLINE]Related articles

Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.

Stakos DA, Schuster DP, Sparks EA, Wooley CF, Osei K, Boudoulas H.

J Cardiol. 2003 Apr;41(4):183-90.PMID: 12728539 [PubMed - indexed for MEDLINE]Related articles